Cabio Biotech (Wuhan) Co., Ltd. (SHA:688089)

Cabio Biotech (Wuhan) Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 22, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,394	3,203	3,013	5,438	7,373	4,752
Market Cap Growth	3.85%	6.31%	-44.60%	-26.24%	55.15%	6.39%
Enterprise Value	3,252	3,077	2,760	4,910	6,676	3,922
Last Close Price	20.35	18.88	17.49	31.30	42.04	26.90
PE Ratio	20.15	25.79	32.97	84.48	57.34	36.39
Forward PE	18.93	22.89	23.21	32.26	-	-
PS Ratio	5.69	5.77	6.79	12.55	21.00	14.69
PB Ratio	2.07	2.04	2.02	3.82	5.34	3.59
P/TBV Ratio	2.14	2.12	2.10	3.93	5.39	3.65
P/FCF Ratio	55.55	-	-	-	-	42.13
P/OCF Ratio	14.08	18.51	43.73	30.83	71.38	32.57
EV/Sales Ratio	5.45	5.54	6.22	11.33	19.02	12.13
EV/EBITDA Ratio	15.30	19.57	22.42	54.31	53.40	28.89
EV/EBIT Ratio	21.42	29.89	36.28	76.29	65.65	35.73
EV/FCF Ratio	53.23	-	-	-	-	34.78
Debt / Equity Ratio	0.06	0.01	0.01	0.02	0.00	-
Debt / EBITDA Ratio	0.49	0.12	0.10	0.36	0.02	-
Debt / FCF Ratio	1.71	-	-	-	-	-
Asset Turnover	0.34	0.34	0.28	0.28	0.25	0.24
Inventory Turnover	2.03	2.60	2.73	3.29	2.46	2.33
Quick Ratio	4.00	4.67	4.77	4.35	14.93	19.82
Current Ratio	5.80	6.45	6.31	5.03	16.59	21.47
Return on Equity (ROE)	10.43%	7.84%	5.92%	4.39%	9.71%	10.49%
Return on Assets (ROA)	5.44%	3.90%	2.95%	2.63%	4.49%	5.12%
Return on Invested Capital (ROIC)	8.96%	6.55%	5.98%	6.19%	14.97%	21.64%
Return on Capital Employed (ROCE)	9.00%	6.50%	5.10%	4.50%	7.30%	8.20%
Earnings Yield	5.00%	3.88%	3.03%	1.18%	1.74%	2.75%
FCF Yield	1.80%	-1.20%	-7.59%	-1.34%	-0.95%	2.37%
Dividend Yield	0.99%	1.06%	1.14%	0.69%	0.56%	0.88%
Payout Ratio	20.53%	27.38%	40.04%	61.90%	31.01%	45.95%
Buyback Yield / Dilution	0.70%	0.80%	0.11%	-0.69%	-0.31%	-32.80%
Total Shareholder Return	1.70%	1.87%	1.26%	-0.01%	0.26%	-31.92%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.